Want to see RKDA full AI Analyst Report?
Arcadia Biosciences (RKDA) Income Statement
Arcadia Biosciences Income Statement
Last quarter (Q2 2026), Arcadia Biosciences's total revenue was $1.44M, a decrease of 0.82% from the same quarter last year. In Q2, Arcadia Biosciences's net income was $-6.27M. See Arcadia Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 4.86M | $ 5.04M | $ 4.45M | $ 7.42M | $ 6.78M | |
| $ 1.76M | $ 2.08M | $ 2.28M | $ 1.32M | $ -1.93M | |
| $ 11.76M | $ 5.73M | $ 8.38M | $ 15.32M | $ 33.60M | |
| Depreciation and Amortization | $ 32.00K | $ 765.00K | $ 287.00K | $ 479.00K | $ 1.04M |
| $ -2.30M | $ -6.85M | $ -5.73M | $ -14.75M | $ -27.71M | |
| $ -9.99M | $ -3.65M | $ -6.10M | $ -14.01M | $ -35.53M | |
| $ 7.66M | $ -661.00K | $ 781.00K | $ 3.19M | $ 19.39M | |
| $ -2.33M | $ -4.31M | $ -5.32M | $ -10.81M | $ -16.13M | |
| $ -2.34M | $ -7.04M | $ -13.98M | $ -15.38M | $ -14.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.71 | $ -5.16 | $ -11.30 | $ -26.05 | $ -30.33 |
| Diluted EPS | $ -1.71 | $ -5.16 | $ -11.30 | $ -26.05 | $ -30.33 |
| Weighted Average Shares Outstanding | 1.37M | 1.36M | 1.24M | 599.39K | 532.01K |
| Weighted Average Shares Outstanding (Diluted) | 1.37M | 1.36M | 1.24M | 599.39K | 532.01K |
Currency in USD